← Back to Search

Continuous Glucose Monitor

CGM4Home for Low Blood Sugar (CGM4Home Trial)

N/A
Waitlist Available
Led By Paulina Cruz Bravo, MD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 1 month and 3 months
Awards & highlights

CGM4Home Trial Summary

This study is evaluating whether a continuous glucose monitor may help improve blood glucose control and quality of life for individuals with poorly controlled diabetes.

Eligible Conditions
  • Low Blood Sugar
  • Hypoglycemia Unawareness
  • High Blood Sugar
  • Type 1 Diabetes
  • Type 2 Diabetes

CGM4Home Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 1 month and 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 1 month and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To Determine the Feasibility of Initiating a Continuous Glucose Monitoring in Patients With Diabetes at Hospital Discharge
Secondary outcome measures
Mean Change in Self-efficacy at 3 Months
Mean Time in Range Outcomes
Percentage of Patients That Discontinue the CGM

CGM4Home Trial Design

1Treatment groups
Experimental Treatment
Group I: CGM InterventionExperimental Treatment1 Intervention
All eligible patients will receive a Continuous Glucose Monitor (CGM) prior to hospital discharge after signing an informed consent.

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,935 Previous Clinical Trials
2,299,787 Total Patients Enrolled
Paulina Cruz Bravo, MDPrincipal Investigator - Washington University School of Medicine
Washington University School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Diabetes Research and Clinical PracticeJournal
Use of a Real Time Continuous Glucose Monitoring System as a Motivational Device for Poorly Controlled Type 2 Diabetes
Yoo, H.J., H.G. An, S.Y. Park, O.H. Ryu, H.Y. Kim, J.A. Seo, E.G. Hong, et al.. 2008. “Use of a Real Time Continuous Glucose Monitoring System as a Motivational Device for Poorly Controlled Type 2 Diabetes”. Diabetes Research and Clinical Practice. Elsevier BV. doi:10.1016/j.diabres.2008.06.015.
Annals of Internal MedicineJournal
Continuous Glucose Monitoring Versus Usual Care in Patients with Type 2 Diabetes Receiving Multiple Daily Insulin Injections
Beck, Roy W., Tonya D. Riddlesworth, Katrina Ruedy, Andrew Ahmann, Stacie Haller, Davida Kruger, Janet B. McGill, et al.. 2017. “Continuous Glucose Monitoring Versus Usual Care in Patients with Type 2 Diabetes Receiving Multiple Daily Insulin Injections”. Annals of Internal Medicine. American College of Physicians. doi:10.7326/m16-2855.
Annals of Internal MedicineJournal
Continuous Glucose Monitoring Versus Usual Care in Patients with Type 2 Diabetes Receiving Multiple Daily Insulin Injections
Beck, Roy W., Tonya D. Riddlesworth, Katrina Ruedy, Andrew Ahmann, Stacie Haller, Davida Kruger, Janet B. McGill, et al.. 2017. “Continuous Glucose Monitoring Versus Usual Care in Patients with Type 2 Diabetes Receiving Multiple Daily Insulin Injections”. Annals of Internal Medicine. American College of Physicians. doi:10.7326/m16-2855.
clinicaltrials.govStudy
Continuous Glucose Monitoring Initiation at Hospital Discharge
Paulina Cruz Bravo 2021. "Continuous Glucose Monitoring Initiation at Hospital Discharge". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04854135.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top